• Aucun résultat trouvé

Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients comparison of psychosocial and health outcomes

N/A
N/A
Protected

Academic year: 2021

Partager "Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients comparison of psychosocial and health outcomes"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: hal-03121088

https://hal.archives-ouvertes.fr/hal-03121088

Submitted on 20 Mar 2021

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients comparison of psychosocial and

health outcomes

Lucile Montalescot, Caroline Bourdon, Cécile de Cazotte, Guillem Pailhez, Antonio Bulbena, Claude Hamonet, Carolina Baeza-Velasco

To cite this version:

Lucile Montalescot, Caroline Bourdon, Cécile de Cazotte, Guillem Pailhez, Antonio Bulbena, et al..

Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients comparison of psychosocial and health outcomes. Colloque international Syndrome d’Ehlers-Danlos, Mar 2017, Paris, France. �hal- 03121088�

(2)

Low- and high-anxious hypermobile Ehlers- Danlos syndrome patients: comparison of psychosocial and health outcomes.

Hypermobile Ehlers-Danlos Syndrome (hEDS) is the most common form of Ehlers-Danlos Syndrome (EDS) (Tinkle et al., 2017) .

High levels of anxiety and anxiety disorders are overrepresented in patients with hEDS (Bulbena et al., 2017) .

• Two hypotheses could explain this frequent co-occurrence: one biological and the other considering anxiety as a response to the burden of the disease (Bulbena et al., 2017 ; Gratacos et al., 2001).

• Despite the high prevalence of anxiety in hEDS patients, little is known about the psychosocial and health implications of such comorbidity.

Lucile Montalescot 1 MSc, Caroline Bourdon 2 MSc, Cécile de Cazotte 1 MSc, Guillem Pailhez 3 MD, PhD, Antonio Bulbena 3 MD, PhD, Claude Hamonet 4,5 MD, PhD & Carolina Baeza-Velasco 1,6 MSc, PhD

1 Laboratory of Psychopathology and Health Processes, University Paris Descartes - Sorbonne Paris Cité, Boulogne-Billancourt, France ; 2 Functional Rehabilitation Center, Evry Hospital, Evry, France ; 3 Department of Psychiatry, Autonoma University of Barcelona, Barcelona, Spain ; 4 Department of Physical Medicine and Rehabilitation, Hôtel-Dieu Hospital, APHP Paris, France ; 5 University Paris-Est Créteil, Créteil, France ; 6 INSERM U1061, Neuropsychiatry: Epidemiological and clinical research. Department of Emergency Psychiatry and Acute Care, CHU Montpellier, Montpellier, France.

High anxiety is common in hEDS and is associated with negative outcomes.

→ An evaluation of anxiety is advisable in order to provide appropriate intervention for hEDS patients.

Population

Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, Pailhez G, Critchley H, Chopra P, Mallorqui-Bagué N, Frank Ch, Porges S (2017) Psychiatric and psychological aspects in the Ehlers- Danlos syndrome. Am J Med Genet 175C:237-245 ; Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, Armengol L, Ponsa I, Miro R, Bulbena A, Estivill X (2001) A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106:367–379 ; Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers-Danlos Syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type):

Clinical description and natural history. Am J Med Genet 175C:48-69.

The aim of this study was to explore the association between high levels of anxiety and psychosocial, health and sociodemographic factors in people with hypermobile Ehlers- Danlos Syndrome.

Measures

72 37,1 y-o

(SD= 11,5)

Sociodemographic and health information

Anxiety

and Depression (HADS)

Social functioning (SF-36)

Somatosensory Amplification

(SAS)

Pain Catastrophizing (PCS)

General Health (SF-36)

= =

+ -

- +

- +

+ + +

- - -

Usual fatigue

Contact: carolina.baeza-velasco@parisdescartes.fr

High-Anxious Low-Anxious

More information: Baeza-Velasco C, Bourdon C, Montalescot L, de Cazotte C, Pailhez G, Bulbena A, Hamonet C. (in press) Low- and high-anxious hypermobile Ehlers-Danlos patients: comparison of psychosocial and health variables. Rheumatology

International.

Références

Documents relatifs

En revanche, pour les patientes porteuses d’un SED de type vasculaire (type IV), se pose le proble`me du type d’anesthe´sie pour la ce´sarienne ou de l’analge´sie si le travail

In conclusion, this retrospective study showed encouraging results with a significant improvement for functional capacity, kinesiophobia, the impact of fatigue on activity and

Les douleurs sont un motif très fréquent de consultation pour les patients atteints d’un syndrome d’Ehlers-Danlos.. Leurs expressions polymorphes et leurs caractères

Musculocontractural Ehlers–Danlos Syndrome (mcEDS) is a rare connective tissue disorder, caused by biallelic loss-of-function variants in CHST14 (mcEDS-CHST14) (MIM#601776) or in

When comparing step counts with recommended values (i.e., 7500 steps/day), both patient groups scored significantly lower (p≤0.001, 70% and 81% of the adults with hEDS and

Table 1 Apparent kinetic parameters of the membrane wild type and mutated β1,4GalTs7 expressed in CHO618 cells towards donor i.e., UDP-Gal and acceptor substrates i.e., pNP-Xyl..

of lifetime and 12-month cases with comorbid DSM-IV anxiety disorders, the proportions of lifetime comorbid cases with anxiety disorder or MDD temporally primary AOO,

Therefore, the purpose of this study was twofold: (i) to assess the impact of somatosensory deficit on subjective visual vertical (SVV) and postural stability; and (ii) to quantify